Menachem Shalom (Menchi) is the son of Miriam and Rabbi Shmuel Landon. Menchi is 2 years old, and has an advanced Stage IV cancer called neuroblastoma.  The Landons have done extensive chemotherapy, surgery, stem-cell transplant and radiation at both Children's Healthcare of Atlanta and at Wolfson Children's Hospital in Jacksonville. They have now been directed to Sloan Kettering in New York for a procedure that could potentially create antibodies that will attack the cancer cells internally.  In general, the survival rate is 30 percent, but Sloan Kettering says that with this procedure there is a 50 percent survival rate. The Landons' insurance does not cover this procedure in New York. Sloan Kettering will not start the five month treatment without a $125,000 retainer, which they must raise by Thursday, Dec. 4th. It is important that they begin this treatment immediately, as Menchi had a stem cell transplant 120 days ago and this procedure is best done within 100 days of the transplant.

Mesora asks your two acts of kindness:
1) Contribute at Mesora's standard Donations page below.100% of your support goes directly for the procedure:
2) Forward this email by
Clicking Here.

At times, tragedies are sudden and we are helpless.
But in situations as these: we can...we must do something. / The JewishTimes /

553 Central Ave. 19A
Cedarhurst, NY 11516
516-569-8888 p
516-569-0404 f